News

Aspiro Co-founders Leading $3.8M NIH Study on Early Detection of COPD

Aspiro Therapeutics Establishes Advisory Board to Support Development of Lead Therapy

Aspiro Therapeutics Selected to Present at 2025 BIO Startup Stadium

Aspiro Therapeutics Selected to Present at 2025 Respiratory Innovation Summit

Aspiro Therapeutics Named Finalist in Flinn Foundation Bioscience Entrepreneurship Program

Aspiro Therapeutics CEO to Attend BIO CEO & Investor Conference 2025